GI
SUPN icon

GAMMA Investing’s Supernus Pharmaceuticals SUPN Stock Holding History

GAMMA Investing’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Sell
3,163
-122
-4% -$5.86K 0.01% 1516
2026
Q1 		$170K Sell
3,285
-2,547
-44% -$130K 0.01% 1238
2025
Q4 		$290K Sell
5,832
-100
-2% -$4.86K 0.01% 785
2025
Q3 		$283K Buy
5,932
+3,071
+107% +$124K 0.02% 749
2025
Q2 		$90.2K Buy
2,861
+1,541
+117% +$49.4K 0.01% 1528
2025
Q1 		$43.2K Buy
1,320
+267
+25% +$9.46K ﹤0.01% 1891
2024
Q4 		$38.1K Buy
1,053
+245
+30% +$8.63K ﹤0.01% 1866
2024
Q3 		$25.2K Buy
808
+398
+97% +$12.4K ﹤0.01% 1964
2024
Q2 		$11K Sell
410
-26
-6% -$754 ﹤0.01% 2202
2024
Q1 		$14.9K Buy
436
+169
+63% +$5.03K ﹤0.01% 1838
2023
Q4 		$7.39K Buy
+267
New +$7.08K ﹤0.01% 2055

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

GAMMA Investing's SUPN Position: Q2 2026 in Review

GAMMA Investing reduced its Supernus Pharmaceuticals (SUPN) stake by 3.7% in Q2 2026, selling an estimated $5.86K and leaving 3,163 shares worth $147K. The position accounts for 0.01% of the portfolio, ranked #1516.

GAMMA Investing first reported a position in SUPN in Q4 2023 and has held it in 11 quarters since. The position peaked at $290K in Q4 2025. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • GAMMA Investing held 3,163 shares of Supernus Pharmaceuticals worth $147K as of Q2 2026.
  • GAMMA Investing sold 122 Supernus Pharmaceuticals shares in Q2 2026, an estimated $5.86K.
  • Supernus Pharmaceuticals made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1516 holding.
  • GAMMA Investing first reported a position in Supernus Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Supernus Pharmaceuticals position peaked at $290K in Q4 2025.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.